Evidence map›Paper›PMID 21057920›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2011

In situ ligation: a decade and a half of experience.

Peter J Hornsby, Vladimir V Didenko

Abstract readReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Quick Detection of DNase II-Type Breaks in Formalin-Fixed Tissue Sections.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peter J HornsbyDepartment of Physiology, Sam and Ann Barshop Center for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX, USA.
Vladimir V Didenko

Funding

Ligatable fluorescent probes using energy transfer for apoptosis detectionR01NS062842 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2009 to 2012
$994k
Semi-artificial nanomachines for detection of DNA damage and apoptosisR21EB006301 · NIBIB · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2006 to 2008
$487k
Assay for dual detection of apoptosisR21NS064403 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DIDENKO, VLADIMIR V · 2009 to 2010
$409k
NIBIB NIH HHS R21 EB006301NINDS NIH HHS R01 NS062842NINDS NIH HHS R21 NS064403
6 · The paper itself

Abstract

The in situ ligation (ISL) methodology detects apoptotic cells by the presence of characteristic DNA double-strand breaks. A labeled double-stranded probe is ligated to the double-strand breaks in situ on tissue sections. Like the popular TUNEL assay, ISL detects cells in apoptosis based on the ongoing destruction of DNA by apoptotic nucleases. In comparison to TUNEL, it is more specific for apoptosis versus other causes of DNA damage, both repairable damage and necrosis. In the decade and a half since its introduction, ISL has been used in several hundred publications. Here we review the development of the method, its current status, and its uses and limitations.

Indexed as

Genetic TechniquesMolecular Probe TechniquesAnimalsDNA Polymerase IImmunohistochemistryIn Situ Nick-End LabelingDNA Polymerase I

Identifiers

PMID21057920
PMCPMC3324560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.